Showing results (1-10 of 723) with videos related to
Sort By:
Pageof 73
Future Cardiology|October 15, 2021
Transcriptomic therapy for dyslipidemias utilizing nucleic acids targeted at ANGPTL3Gerald F Watts, Frederick J Raal, Dick C ChanAtherosclerosis. Supplements|May 11, 2010
Mechanisms for therapeutic correction of dyslipidaemia in insulin resistance and diabetesGerald F Watts, Dick C ChanClinical Laboratory|September 8, 2006
Recent advances in the investigation of lipoprotein metabolism using tracer methodologyDick C Chan, Gerald F WattsMetabolism: Clinical and Experimental|September 28, 2011
Postprandial lipoprotein metabolism in familial hypercholesterolemia: thinking outside the boxDick C Chan, Gerald F WattsCurrent Vascular Pharmacology|January 29, 2008
Pharmacological regulation of dyslipoproteinaemia in insulin resistant statesDick C Chan, Gerald F WattsExpert Opinion on Pharmacotherapy|July 16, 2010
Dyslipidaemia in the metabolic syndrome and type 2 diabetes: pathogenesis, priorities, pharmacotherapiesDick C Chan, Gerald F WattsCurrent Atherosclerosis Reports|November 20, 2024
Inhibition of the ANGPTL3/8 Complex for the Prevention and Treatment of Atherosclerotic Cardiovascular DiseaseDick C Chan, Gerald F WattsCurrent Opinion in Lipidology|February 19, 2024
ANGPTL3 and ApoC-III inhibitors for treating hypertriglyceridemia in context: horses for courses?Dick C Chan, Gerald F WattsClinical Therapeutics|July 31, 2023
The Promise of PCSK9 and Lipoprotein(a) as Targets for Gene Silencing TherapiesDick C Chan, Gerald F WattsFrontiers in Physiology|March 1, 2021
New Insights Into the Regulation of Lipoprotein Metabolism by PCSK9: Lessons From Stable Isotope Tracer Studies in Human SubjectsQidi Ying, Dick C Chan, Gerald F WattsPageof 73